JPMorgan Chase & Co’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $127 | Hold |
|
|||||
|
2024
Q3 | $1.18K | Hold |
|
|||||
|
2024
Q2 | $2.83K | Hold |
|
|||||
|
2024
Q1 | $2.94K | Hold |
|
|||||
|
2023
Q4 | $4.28K | Sell |
|
|||||
|
2023
Q3 | $4.25K | Buy |
|
|||||
|
2023
Q2 | $1.88K | Hold |
|
|||||
|
2023
Q1 | $2K | Hold |
|
|||||
|
2022
Q4 | $2K | Sell |
|
|||||
|
2022
Q3 | $5K | Buy |
|
|||||
|
2022
Q2 | $3K | Sell |
|
|||||
|
2022
Q1 | $41K | Buy |
|
|||||
|
2021
Q4 | $91K | Buy |
|
|||||
|
2021
Q3 | $120K | Sell |
|
|||||
|
2021
Q2 | $1M | Sell |
|
|||||
|
2021
Q1 | $4.97M | Sell |
|
|||||
|
2020
Q4 | $7.98M | Buy |
|
|||||
|
2020
Q3 | $7M | Sell |
|
|||||
|
2020
Q2 | $8.46M | Sell |
|
|||||
|
2020
Q1 | $5.23M | Sell |
|
|||||
|
2019
Q4 | $6.54M | Buy |
|
|||||
|
2019
Q3 | $4.37M | Buy |
|
|||||
|
2019
Q2 | $3.24M | Buy |
|
|||||
|
2019
Q1 | $3.67M | Sell |
|
|||||
|
2018
Q4 | $2.24M | Buy |
|
|||||
|
2018
Q3 | $4.41M | Buy |
|
|||||
|
2018
Q2 | $3.69M | Sell |
|
|||||
|
2018
Q1 | $4.86M | Buy |
|
|||||
|
2017
Q4 | $3.2M | Buy |
|
|||||
|
2017
Q3 | $1.93M | Buy |
|
|||||
|
2017
Q2 | $1.76M | Sell |
|
|||||
|
2017
Q1 | $1.92M | Sell |
|
|||||
|
2016
Q4 | $1.57M | Sell |
|
|||||
|
2016
Q3 | $1.89M | Buy |
|